Why the study?
Anticoagulant therapy may be required in AF to prevent cerebral embolism, but the current status of antithrombotic therapy prior to the onset of cardioembolic stroke needed evaluation.
This study highlights a significant gap in clinical practice, demonstrating that the majority of patients presenting with AF-related cardioembolic stroke were not receiving appropriate pre-onset anticoagulant therapy.
Gaps in pre-stroke anticoagulation for known AF persist; leaves open implementation research to improve real-world adherence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kitagawa et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: